Vivos Therapeutics (VVOS) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Vivos Therapeutics (VVOS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||
Total Revenue | 5.14M (+34.55%) | 3.82M (-43.66%) | 6.78M (+77.49%) | 3.82M (+26.49%) | 3.02M (-18.38%) | 3.70M (-4.15%) | 3.86M (-4.69%) | 4.05M (+18.42%) | 3.42M (+5.23%) | 3.25M (-1.52%) | 3.30M (-2.94%) | 3.40M (-11.92%) | 3.86M (-9.18%) | 4.25M (+1.67%) | 4.18M (+14.84%) | 3.64M | - | 4.55M (+1.11%) | 4.50M (+30.43%) | 3.45M (+4.23%) | 3.31M (+0.61%) | 3.29M (+0.61%) | 3.27M (+2.19%) | 3.20M |
Cost Of Revenue | - | 6.90M | - | - | - | 6.01M | - | - | - | 5.53M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | - | 6.90M | - | - | - | 6.01M | - | - | - | 5.53M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 3.06M (+2.34%) | 2.99M (-24.11%) | 3.94M (+86.73%) | 2.11M (+39.74%) | 1.51M (-28.10%) | 2.10M (-9.87%) | 2.33M (-12.08%) | 2.65M (+36.60%) | 1.94M (-7.18%) | 2.09M (+19.43%) | 1.75M (-16.67%) | 2.10M (-10.26%) | 2.34M (-6.40%) | 2.50M (-3.47%) | 2.59M (+1.57%) | 2.55M | - | 3.18M (-12.15%) | 3.62M (+34.57%) | 2.69M (0.00%) | 2.69M (+4.26%) | 2.58M (-5.49%) | 2.73M (+12.81%) | 2.42M |
Operating Expenses | ||||||||||||||||||||||||
Research And Development | - | 100K | - | - | - | - | - | - | 100K | -200.00K | 100K (0.00%) | 100K (0.00%) | 100K (0.00%) | 100K (0.00%) | 100K (0.00%) | 100K | - | 100K (0.00%) | 100K (0.00%) | 100K | - | - | - | - |
Selling General And Administrative | 8.97M (+5.04%) | 8.54M (+8.38%) | 7.88M (+22.93%) | 6.41M (+31.08%) | 4.89M (+12.41%) | 4.35M (-3.12%) | 4.49M (+8.98%) | 4.12M (-16.26%) | 4.92M (-10.05%) | 5.47M (+18.91%) | 4.60M (-21.77%) | 5.88M (-10.09%) | 6.54M (-1.21%) | 6.62M (-13.91%) | 7.69M (-7.13%) | 8.28M | - | 6.52M (+7.06%) | 6.09M (+20.36%) | 5.06M (+9.76%) | 4.61M (+21.64%) | 3.79M (+9.54%) | 3.46M (-18.20%) | 4.23M |
Operating Expenses | 9.67M (+3.31%) | 9.36M (+7.96%) | 8.67M (+24.21%) | 6.98M (+28.55%) | 5.43M (+10.82%) | 4.90M (-1.61%) | 4.98M (+8.50%) | 4.59M (-19.76%) | 5.72M (-8.04%) | 6.22M (+15.40%) | 5.39M (-18.58%) | 6.62M (-9.81%) | 7.34M (-7.09%) | 7.90M (-17.28%) | 9.55M (+3.92%) | 9.19M | - | 8.69M (+13.00%) | 7.69M (+26.07%) | 6.10M (-31.77%) | 8.94M (+103.18%) | 4.40M (+6.28%) | 4.14M (-16.70%) | 4.97M |
Depreciation And Amortization | 450K (+2.27%) | 440K (+15.79%) | 380K (+22.58%) | 310K (+72.22%) | 180K (+28.57%) | 140K (-6.67%) | 150K (+7.14%) | 140K (-6.67%) | 150K (0.00%) | 150K (0.00%) | 150K (0.00%) | 150K (-16.67%) | 180K (0.00%) | 180K (+12.50%) | 160K (+300.00%) | 40K | - | 190K (-5.00%) | 200K (+11.11%) | 180K (0.00%) | 180K (0.00%) | 180K (0.00%) | 180K (0.00%) | 180K |
Operating Income | ||||||||||||||||||||||||
Operating Income | -6.61M (+3.61%) | -6.38M (+34.88%) | -4.73M (-2.67%) | -4.86M (+23.98%) | -3.92M (+40.00%) | -2.80M (+6.06%) | -2.64M (+36.08%) | -1.94M (-48.68%) | -3.78M (-8.47%) | -4.13M (+13.46%) | -3.64M (-19.47%) | -4.52M (-9.60%) | -5.00M (-7.58%) | -5.41M (-22.27%) | -6.96M (+4.82%) | -6.64M | - | -5.50M (+35.47%) | -4.06M (+19.06%) | -3.41M (-45.44%) | -6.25M (+243.41%) | -1.82M (+28.17%) | -1.42M (-44.53%) | -2.56M |
Ebit | -6.61M (+3.61%) | -6.38M (+34.88%) | -4.73M (-2.67%) | -4.86M (+23.98%) | -3.92M (+40.00%) | -2.80M (+6.06%) | -2.64M (+36.08%) | -1.94M (-48.68%) | -3.78M (-8.47%) | -4.13M (+13.46%) | -3.64M (-19.47%) | -4.52M (-9.60%) | -5.00M (-7.58%) | -5.41M (-22.27%) | -6.96M (+4.82%) | -6.64M | 20M | -5.50M (+35.47%) | -4.06M (+19.06%) | -3.41M (-45.44%) | -6.25M (+243.41%) | -1.82M (+28.17%) | -1.42M (-44.53%) | -2.56M |
EBITDA | -6.16M (+3.88%) | -5.93M (+36.32%) | -4.35M (-4.61%) | -4.56M (+21.93%) | -3.74M (+40.60%) | -2.66M (+6.40%) | -2.50M (+39.66%) | -1.79M (-50.82%) | -3.64M (-8.77%) | -3.99M (+14.33%) | -3.49M (-20.14%) | -4.37M (-9.52%) | -4.83M (-7.65%) | -5.23M (-23.09%) | -6.80M (+3.03%) | -6.60M | 20M | -5.31M (+37.21%) | -3.87M (+19.81%) | -3.23M (-46.79%) | -6.07M (+270.12%) | -1.64M (+32.26%) | -1.24M (-47.90%) | -2.38M |
Other Income / Expenses | ||||||||||||||||||||||||
Interest Expense | 1.10M (+22.22%) | 900K (+80.00%) | 500K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K | - | - | 20K (0.00%) | 20K (0.00%) | 20K (-50.00%) | 40K |
Net Interest Income | -1.10M (+22.22%) | -900.00K (+80.00%) | -500.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K | - | - | -20.00K (0.00%) | -20.00K (0.00%) | -20.00K (-50.00%) | -40.00K |
Other Non Operating Income | -1.17M (-20.95%) | -1.48M (+117.65%) | -680.00K (+325.00%) | -160.00K | - | -110.00K (+450.00%) | -20.00K (0.00%) | -20.00K | - | -210.00K (+320.00%) | -50.00K (-77.27%) | -220.00K | 50K | -40.00K (0.00%) | -40.00K (0.00%) | -40.00K | - | - | - | - | - | - | - | - |
Net Income | ||||||||||||||||||||||||
Income Before Tax | -7.75M (+11.51%) | -6.95M (+28.70%) | -5.40M (+7.78%) | -5.01M (+29.79%) | -3.86M (+36.40%) | -2.83M (+8.02%) | -2.62M (+35.75%) | -1.93M (-48.67%) | -3.76M (-11.74%) | -4.26M (+103.83%) | -2.09M (-62.21%) | -5.53M (+225.29%) | -1.70M (-68.69%) | -5.43M (-22.32%) | -6.99M (+26.86%) | -5.51M | - | -5.45M (+34.90%) | -4.04M (+18.82%) | -3.40M (-71.81%) | -12.06M | - | - | - |
Net Income From Continuing Operations | -7.68M (+11.47%) | -6.89M (+27.59%) | -5.40M (+7.78%) | -5.01M (+29.79%) | -3.86M (+36.40%) | -2.83M (+8.02%) | -2.62M (+35.75%) | -1.93M (-48.67%) | -3.76M (-11.74%) | -4.26M (+103.83%) | -2.09M (-62.21%) | -5.53M (+225.29%) | -1.70M (-68.69%) | -5.43M (-22.32%) | -6.99M (+31.14%) | -5.33M | 20M | -5.45M (+34.90%) | -4.04M (+18.82%) | -3.40M (-45.60%) | -6.25M (+245.30%) | -1.81M (+28.37%) | -1.41M (-45.35%) | -2.58M |
Net Income | -7.68M (+11.47%) | -6.89M (+27.59%) | -5.40M (+7.78%) | -5.01M (+29.79%) | -3.86M (+36.40%) | -2.83M (+8.02%) | -2.62M (+35.75%) | -1.93M (-48.67%) | -3.76M (-11.74%) | -4.26M (+103.83%) | -2.09M (-62.21%) | -5.53M (+225.29%) | -1.70M (-68.69%) | -5.43M (-22.32%) | -6.99M (+31.14%) | -5.33M | 20M | -5.45M (+34.90%) | -4.04M (+18.82%) | -3.40M (-45.60%) | -6.25M (+245.30%) | -1.81M (+28.37%) | -1.41M (-45.35%) | -2.58M |